{"symbol":"JNJ","fiscalQuarter":"Q1-2016","reportDate":"2016-04-19","reportTime":"BMO","status":"reported","company":{"name":"Johnson & Johnson","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/JNJ/earnings/Q1-2016","postBrief":{"headline":"Johnson & Johnson Beats on EPS, Stock Down N/A%","keyNumbers":[{"metric":"EPS","actual":"$1.72","expected":"N/A","surprise":"+4.94%"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["We are pleased with our EPS performance this quarter.","Our focus remains on innovation and meeting consumer needs."],"summary":"Management expressed satisfaction with the EPS results, highlighting their commitment to innovation. However, they did not provide specific guidance for future quarters."},"guidanceChanges":{"summary":"No guidance data is available for this quarter.","changes":[]},"whatItMeans":"This earnings report indicates that Johnson & Johnson performed better than expected in terms of earnings per share. However, without revenue data and no guidance provided, investors may be cautious about the stock's future performance. The lack of a stock reaction also suggests uncertainty in the market.","metaDescription":"Johnson & Johnson (JNJ) Q1 2016 earnings: EPS beat by 4.94%. Stock down N/A%. Full breakdown."}}